CLINICAL_TRIALS
trial_result
· 2019-10-02
Clinical Trial Update: Repurposing Dexmedetomidine as an Orally Administered Sleep Therapeutic [Phase 1, Phase 2]
Summary
Phase 1/2 clinical trial exploring oral dexmedetomidine as a sleep therapeutic for insomnia completed with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Sleep, Insomnia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-10-02